| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 211,1 k € | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||
| Gross margin | 155,2 k € | +130.8% | 67,3 k € | -14.9% | 79,0 k € | +127.7% | 34,7 k € | +42.9% | 24,3 k € | -36.7% | 38,4 k € | -11.4% | 43,3 k € | -13.1% | 49,8 k € | -2.9% | 51,3 k € | -15.3% | 60,6 k € | -0.5% | 60,9 k € | -0.6% | 61,3 k € | +0.8% | 60,8 k € | -4.9% | 64,0 k € | -25.4% | 85,8 k € | +20.3% | 71,3 k € | +2.4% | 69,7 k € | +23.4% | 56,5 k € | |
| EBITDA | 148,2 k € | +130.5% | 64,3 k € | -15.8% | 76,4 k € | +137.1% | 32,2 k € | +47.9% | 21,8 k € | -39.6% | 36,0 k € | -10.6% | 40,3 k € | -14.3% | 47,0 k € | -4.3% | 49,1 k € | -15.9% | 58,4 k € | -0.3% | 58,6 k € | -1.2% | 59,4 k € | +1.2% | 58,7 k € | -5.4% | 62,1 k € | -25.8% | 83,6 k € | +20.9% | 69,2 k € | +2.0% | 67,8 k € | +24.7% | 54,4 k € | |
| Operating profit | 121,6 k € | +170.9% | 44,9 k € | -22.6% | 57,9 k € | +313.3% | 14,0 k € | +134.2% | 6,0 k € | -68.8% | 19,2 k € | -3.7% | 19,9 k € | -19.3% | 24,7 k € | +42.7% | 17,3 k € | -32.8% | 25,8 k € | +15.0% | 22,4 k € | +42.4% | 15,7 k € | +9.8% | 14,3 k € | -45.1% | 26,1 k € | -30.5% | 37,5 k € | +52.4% | 24,6 k € | +4.4% | 23,6 k € | +125.4% | 10,5 k € | |
| Profit/loss | 77,6 k € | +173.8% | 28,4 k € | -26.3% | 38,5 k € | +516.7% | 6,2 k € | +6559.6% | 93,7 € | -99.3% | 12,9 k € | -27.5% | 17,8 k € | -29.3% | 25,2 k € | +106.5% | 12,2 k € | -47.8% | 23,4 k € | -17.5% | 28,3 k € | +56.7% | 18,1 k € | +40.0% | 12,9 k € | -29.2% | 18,2 k € | -25.5% | 24,5 k € | +114.0% | 11,4 k € | +17.1% | 9,8 k € | +33452.5% | 29,1 € | |
| Equity | 316,6 k € | +32.5% | 239,0 k € | +13.5% | 210,7 k € | +7.7% | 195,5 k € | +3.3% | 189,3 k € | +0.0% | 189,2 k € | +7.3% | 176,3 k € | -47.9% | 338,5 k € | +20.9% | 280,0 k € | +4.6% | 267,8 k € | +315.9% | 64,4 k € | -72.7% | 236,1 k € | +8.3% | 218,0 k € | +6.3% | 205,1 k € | +9.8% | 186,8 k € | +15.1% | 162,3 k € | +7.6% | 150,9 k € | +6.9% | 141,1 k € | |
| Total assets | 381,6 k € | +22.5% | 311,4 k € | +3.7% | 300,4 k € | +5.2% | 285,6 k € | -4.1% | 297,9 k € | -6.1% | 317,1 k € | -6.2% | 338,0 k € | -36.9% | 535,9 k € | +4.0% | 515,1 k € | -5.6% | 546,0 k € | -2.8% | 561,5 k € | +0.3% | 560,0 k € | -2.3% | 572,9 k € | +6.3% | 539,0 k € | +1.1% | 533,3 k € | +3.6% | 514,8 k € | +6.5% | 483,4 k € | -1.8% | 492,5 k € | |
| Cash | 144,7 k € | +16.4% | 124,3 k € | -17.0% | 149,8 k € | +22.6% | 122,2 k € | +1.0% | 121,0 k € | -29.2% | 170,8 k € | +22.2% | 139,8 k € | +438.2% | 26,0 k € | +193.8% | 8,8 k € | -63.4% | 24,1 k € | +128.5% | 10,6 k € | +167.4% | 4,0 k € | -72.0% | 14,1 k € | -41.9% | 24,3 k € | +35.8% | 17,9 k € | -60.2% | 45,0 k € | -12.7% | 51,6 k € | +0.6% | 51,2 k € | |
| Debts | 64,9 k € | -9.1% | 71,5 k € | -19.5% | 88,8 k € | -1.4% | 90,0 k € | -17.1% | 108,6 k € | -15.1% | 127,9 k € | -20.9% | 161,7 k € | -18.1% | 197,4 k € | -16.0% | 235,2 k € | -15.5% | 278,2 k € | -44.0% | 497,2 k € | +53.5% | 323,9 k € | -8.7% | 354,9 k € | +6.3% | 334,0 k € | -3.6% | 346,5 k € | -1.7% | 352,5 k € | +6.4% | 331,3 k € | -5.7% | 351,3 k € | |
Private company with limited liability · Tielt · incorporated on 01/02/1996
Private company with limited liability profitable and well capitalised. Cash position rising (+16.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. HANS CUYPERS is a Private company with limited liability incorporated in 1996. Its main activity is: General medical practice activities. Its registered office is in Tielt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette